5th Annual ECD Medical Symposium New York, NY
New York Medical Symposium Group Picture 2017
Symposium Summary
Approximately 65 medical professionals from eight countries attended the Annual ECD Medical Symposium in 2017. 18 oral abstracts were presented, along with an additional five poster presentations. Neal Rosen, MD, PhD, delivered an invited talk. An evening reception provided time for discussions supporting current and future collaborations among this highly knowledgeable group of physicians and scientists, all interested in learning more about Erdheim-Chester Disease.
Programs with Symposium Agenda
Presentations
The following presentations have been added in hopes that it will help other physicians and researchers that are interested in learning more about ECD. The ECDGA is grateful for the efforts and contributions made by the medical community to improve care for ECD patients.
| Presenter | Presentation Slides | English Video |
|---|---|---|
| Ankush Bhatia, MD | Single-agent dabrafenib for BRAFV600E-mutated histiocytosis | Not available. |
| Riccardo Biavasco, MD | BRAFV600E expression in hematopoietic progenitors leads to myeloid skewing and histiocytosis | Not available. |
| Pascale Chasseur, MD | A cytologic diagnosis of BRAFV600E Erdheim-Chester disease on pericardial fluid | Not available. |
| Marina Ferrarini, MD | 3-D culture of BRAF and KRAS-mutated Erdheim-Chester disease tissues: impact of kinase inhibitors | Not available. |
| Aaron Goodman, MD | Genomics of Erdheim Chester Disease: Implications for Precision Treatment with Targeted Therapy | Not available. |
| Gaurav Goyal, MBBS | Efficacy of Biologic Agents in the Treatment of Erdheim-Chester Disease | Not available. |
| Gaurav Goyal, MBBS | Increased prevalence of myeloid neoplasms in patients with Erdheim-Chester disease | Not available. |
| Julien Haroche, MD, PhD | BRAF V600E mutation is associated with a cardiac and neurological phenotype in Erdheim-Chester disease: results from a 165-patient cohort | Not available. |
| Filip Janku, MD, PhD | Clinical molecular profiling of archival tumor tissue and cell-free DNA from patients with Erdheim-Chester disease | Not available. |
| Augusto Vaglio, MD | Renal and ureteral involvement in Erdheim-Chester disease: analysis of a single centre cohort | Not available. |
| Neal Rosen, MD, PhD | Not available. | Not available. |
| Juvianee Estrada-Veras, MD | Adult Patients with Mixed Histiocytosis: Cases from the NIH Clinical Center | Not available. |
| Benjamin H. Durham, MD | Genomic Analysis Identifies Novel Kinase Alterations in the Histiocytic Neoplasms | Not available. |
| Domenico Corradi, MD | Pro-Collagen Type I Expression In Foamy Histiocytes From Erdheim-Chester Disease Biopsies | Not available. |
| Eli L. Diamond, MD | Phase 2 Trial of Single-Agent Cobimetinib for Adults with Histiocytic Disorders: Interim Results | Not available. |
| Disha Dalela, MBBS | The Masquerader- ECD presenting as PUO | Not available. |
| Rahul H. Dave, MD, PhD | Neurologic Involvement in Erdheim-Chester Disease | Not available. |
| S. Mojdeh Mirmomen and Moozhan Nikpanah | Abdominal and Thoracic Imaging Presentations of 61 Cases of ECD: Association with BRAFV600E Mutation | Not available. |
| Roei Mazor, MD | Comparative Analysis of Tandem PET/CT & PET/MR Studies in the Evaluation of Patients with Inflammatory Myeloid Neoplasms | Not available. |
| Eli L. Diamond, MD | IMPACT: MSKCC targeted tumor sequencing test available for ECD patients | Not available. |
| Eli L. Diamond, MD | Update Consensus Guidelines | Not available. |
| Mark Heaney, MD, PhD, Eli L. Diamond, MD, Kathleen Brewer | Closing | Not available. |
Photographs
Medical Symposium
Medical Reception
The following photos were taken during the ECD Medical Symposium on October 27 in New York, NY. Thank you to all participants and speakers for a fulfilling and enlightening experience at this event. Please join us again on November 15, 2018 in Orlando! Please also see the Patient & Family Gathering page for more.
